Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Non-Current Debt (2020 - 2026)

Updated

Inhibitor Therapeutics' Non-Current Debt was $273,638 in FY2014, down 25.3% from $366,130 in FY2013.

Analysis

Inhibitor Therapeutics (INTI) Non-Current Debt (2020 - 2026) Analysis & Trends

  • Per Business Quant data, Non-Current Debt in earlier years was $366,130 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn - 21,566.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21,566.00
Mar 31, 2026 29,380.00
Dec 31, 2025 36,889.00
Sep 30, 2025 44,181.00
Jun 30, 2025 52,064.00
Mar 31, 2025 58,361.00
Sep 30, 2021 38,500.00
Jun 30, 2021 96,250.00
Mar 31, 2021 104,000.00
Dec 31, 2020 55,000.00
Sep 30, 2020 18,489.00
Jun 30, 2020 25,422.00
API Access

Inhibitor Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INTI&period=max&api_key=YOUR_API_KEY